The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of multidisciplinary severe immunotherapy complication service on outcomes for cancer patients receiving immune checkpoint inhibition.
 
Leyre Zubiri
Consulting or Advisory Role - Merck
 
Gabriel E. Molina
No Relationships to Disclose
 
Meghan Mooradian
Consulting or Advisory Role - AstraZeneca; Nektar
 
Sienna Durbin
No Relationships to Disclose
 
Michael Dougan
Consulting or Advisory Role - Moderna Therapeutics; Neoleukin Therapeutics; ORIC Pharmaceuticals; Partner Therapeutics; Tillotts Pharma
Research Funding - Lilly; Novartis
 
Molly Thomas
No Relationships to Disclose
 
Alexander Faje
No Relationships to Disclose
 
Michelle Rengarajan
No Relationships to Disclose
 
Amanda C Guidon
Employment - GE Healthcare (I)
Stock and Other Ownership Interests - GE Healthcare (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Ra Pharma
Research Funding - Momenta Pharmaceuticals; Myasthenia Gravis Foundation of America; Ra Pharma
Patents, Royalties, Other Intellectual Property - Comprehensive Review of Neuromuscular and Electrodiagnostic Medicine, The Oakstone Institute, 2014, 2016 and 2018.
 
Steven T. Chen
No Relationships to Disclose
 
Mazen Nasrallah
No Relationships to Disclose
 
Minna Kohler
Consulting or Advisory Role - Mymee; Novartis
Speakers' Bureau - Lilly
 
Meghan Sise
No Relationships to Disclose
 
Tomas G Neilan
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; H3 Biomedicine; Intrinsic Imaging; Parexel
Research Funding - AstraZeneca
 
Daniel A Zlotoff
No Relationships to Disclose
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Ryan J. Sullivan
Consulting or Advisory Role - alkermes; Asana Biosciences; AstraZeneca; Bristol-Myers Squibb; Eisai; Iovance Biotherapeutics; Merck; Novartis; OncoSec; Pfizer; Replimune
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BeiGene (Inst); BioMed Valley Discoveries (Inst); Compugen (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Strategia (Inst); Strategia (Inst); Viralytics (Inst)
 
Yevgeniy R. Semenov
Consulting or Advisory Role - Castle Biosciences
 
Alexandra C Villani
No Relationships to Disclose
 
Kerry Lynn Reynolds
Stock and Other Ownership Interests - Biogen (I)